Skip to content
Nonprofiteer
← AIM-HI ACCELERATOR FUND INC

Form 990 for tax year 2025

Filed by AIM-HI ACCELERATOR FUND INC.

Totals

Total revenue
$1,206,195
Total expenses
$619,686
Contributions and grants received
$1,163,557
Grants paid
$510,000
Program service revenue
$0
Investment income
$42,638
Other revenue
$0
Total assets, end of year
$16,899,865
Total liabilities, end of year
$201,912
Net assets or fund balances, end of year
$16,697,953
Program services expenses (Part IX)
$588,162
Management and general expenses
$29,881
Fundraising expenses
$1,643
Program service expenses (Part III)
$588,162

Program services were 94.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1a , Federated campaigns

    $0

  • 1b , Membership dues

    $0

  • 1c , Fundraising events

    $0

  • 1d , Related organizations

    $0

  • 1e , Government grants (contributions)

    $0

  • 1f , All other contributions, gifts and grants

    $1,163,557

  • 1g , Noncash contributions included above

    $0

  • 3 , Investment income

    total $42,638 · related or exempt $0 · unrelated business $0 · excluded $42,638

  • 4 , Income from investment of tax-exempt bond proceeds

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 5 , Royalties

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 6c , Rental income or loss

    real property $0 · personal property $0

  • 7c , Gain or loss

    securities $0 · other assets $0

  • 8a , Fundraising events: contributions included on line 1c

    $0

  • 11e , Other revenue, total

    $0

Functional expenses

Part IX, the statement of functional expenses.

  • 1 , Grants to domestic organizations and governments

    total $510,000 · program services $510,000

  • 11b , Fees: legal

    total $2,397 · management and general $2,397

  • 11f , Fees: investment management

    total $25,000 · management and general $25,000

  • 13 , Office expenses

    total $841 · management and general $841

  • 14 , Information technology

    total $16,432 · program services $13,146 · management and general $1,643 · fundraising $1,643

  • 17 , Travel

    total $18,270 · program services $18,270

  • 19 , Conferences, conventions and meetings

    total $46,746 · program services $46,746

  • 26 , Joint costs (an allocation of the lines above)

    total $16,432 · program services $13,146 · management and general $1,643 · fundraising $1,643

Balance sheet

Part X, book values.

  • 1 , Cash, non-interest-bearing

    beginning of year $122,259 · end of year $58,041

  • 2 , Savings and temporary cash investments

    beginning of year $1,234,362 · end of year $1,756,999

  • 3 , Pledges and grants receivable

    beginning of year $1,170,000 · end of year $850,000

  • 13 , Investments: program-related

    beginning of year $13,587,906 · end of year $14,234,825

  • 17 , Accounts payable and accrued expenses

    beginning of year $3,083 · end of year $1,912

  • 19 , Deferred revenue

    end of year $200,000

  • 27 , Net assets without donor restrictions

    beginning of year $2,523,538 · end of year $2,463,128

  • 28 , Net assets with donor restrictions

    beginning of year $13,587,906 · end of year $14,234,825

Mission and programs · 2025

Mission

The AIM-HI Accelerator Fund is an independent 501(C)(3) non-profit organization, established with an initial grant from the National Foundation for Cancer Research with the vision to accelerate the translation of cancer drug discoveries by investing in seed-stage companies. It is a new paradigm through venture philanthropy to fund start-up oncology companies that commercialize innovative laboratory breakthroughs which can potentially save cancer patients' lives.

Activities or mission (Part I)

AIM-HI Accelerator Fund Inc's mission is to bridge the gap and accelerate new oncology therapies and technologies across the "Valley of Death" through high-impact investment approaches.

  • Cancer Research Funding: Leveraging immediately deployable venture philanthropy funding to provide seed funding and sustainable impact investment for oncology start-ups to bridge the "Valley of Death" funding gap and bring innovative new therapies, diagnostics and cancer prevention to patients.

    Expenses $510,000 · Grants $510,000

  • Cancer Awareness

    Expenses $78,162

As filed on the 2025 return.

Listed in Part VII

  • Matthew Tremblay

    CHAIRMAN OF THE BOARD

    Total calculated
    $0
    Hours/week
    2
  • Charlie Weatherspoon

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1.5
  • Alfred Slanetz

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Rose Wang

    DIRECTOR

    Total calculated
    $0
    Hours/week
    2
  • Silas Deane

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Sujuan Ba

    CO-FOUNDER AND CEO

    Total calculated
    $0
    Hours/week
    10
  • Kwok Leung

    TREASURER/SECRETARY (SERVED THRU SEPT 2025)

    Total calculated
    $0
    Hours/week
    5

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

Provenance

Return type
form_990
Tax year
2025
IRS schema version
2025v4.0
Source object
202632879349301433

The source document this was parsed from is served over the API, which is where bulk and document access live.